As of my last update in October 2023, MED6-189, identified by the CAS number 2650073-66-6, is a chemical compound that has garnered interest in the field of medicinal chemistry. While specific details about its characteristics may not be widely available, compounds like MED6-189 are typically evaluated for their biological activity, pharmacokinetics, and potential therapeutic applications. Characteristics often assessed include solubility, stability, and reactivity, as well as the compound's mechanism of action in biological systems. Additionally, researchers may investigate its toxicity profile and efficacy in preclinical or clinical studies. The compound's structure-activity relationship (SAR) is also crucial for understanding how modifications to its chemical structure can influence its biological properties. For the most accurate and detailed information, including experimental data and specific applications, consulting scientific literature or databases dedicated to chemical substances is recommended.

MED6-189

2650073-66-6: As of my last update in October 2023, MED6-189, identified by the CAS number 2650073-66-6, is a chemical compound that has garnered interest in the field of medicinal chemistry. While specific details about its characteristics may not be widely available, compounds like MED6-189 are typically evaluated for their biological activity, pharmacokinetics, and potential therapeutic applications. Characteristics often assessed include solubility, stability, and reactivity, as well as the compound's mechanism of action in biological systems. Additionally, researchers may investigate its toxicity profile and efficacy in preclinical or clinical studies. The compound's structure-activity relationship (SAR) is also crucial for understanding how modifications to its chemical structure can influence its biological properties. For the most accurate and detailed information, including experimental data and specific applications, consulting scientific literature or databases dedicated to chemical substances is recommended.

MED6-189, an analog of kalihinol, disrupts the apicoplast functions and vesicular transport in the malignant malaria parasite (P. falciparum, IC50 < 50 nM). The compound specifically targets the apicoplast, which is a non-photosynthetic plastid essential for isoprenoid synthesis, found in most apicomplexan parasites.

CAS 2650073-66-6

MED6-189

MED6-189

Ref: TM-T201291